文献速递治疗药物监测与药物基因组学药物不良反应与药物警戒

药物基因组学警示:为医疗专业人员制定使用指南

Pharmacogenomic alerts: Developing guidance for use by healthcare professionals.
PubMed 文献 · Br J Clin Pharmacol · 2022-02-14

英国专业记录标准机构受NHS England委托,通过调研英格兰及国际药物基因组学实施者,制定将药物基因组学信息用于临床实践的指南与建议,提出需建立安全提供 curated、可操作、最新信息的系统,并确立通知与信息交换标准,以支持更安全用药。

要点

  • 需建立系统确保药物基因组学信息 curated、可操作且最新。
  • 应制定通知与信息交换标准,与常规实践一致。
  • 警示系统应促进更安全实践,需多学科利益相关者参与标准制定。

核心结论

  • 确保药物基因组学信息可用于更安全用药需重大努力,本指南是开端。
  • 需制定标准,使健康记录中有用基因组信息以正确格式和时机传达给临床医生并成功执行。

研究设计与样本

  • 英国专业记录标准机构受NHS England委托,制定临床实践中使用药物基因组学信息的指南。
  • 对英格兰及国际药物基因组学实施者开展研究,形成基于系统方法的指南与建议。

主要发现

  • 共识观点认为需建立系统确保安全提供 curated、可操作且最新的药物基因组学信息。
  • 应确立通知与信息交换标准,可影响新或现有处方且须与常规实践一致。
  • 警示系统应促进更安全实践。

临床怎么用

  • 临床应将药物基因组学警示整合入处方流程,确保信息及时可操作。
  • 多学科利益相关者应参与制定药物基因组学标准以支持最适当处方。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: For diseases with a genetic cause, genomics can deliver improved diagnostics and facilitate access to targeted treatments. Drug pharmacodynamics and pharmacokinetics are often dependent on genetic variation underlying these processes. As pharmacogenomics comes of age, it may be the first way in which genomics is utilised at a population level. Still required is guidance and standards of how genomic information can be communicated within the health record, and how clinicians should be alerted to variation impacting the use of medicines. METHODS: The Professional Record Standards Body commissioned by NHS England developed guidance on using pharmacogenomics information in clinical practice. We conducted research with those implementing pharmacogenomics in England and internationally to produce guidance and recommendations for a systems-based approach. RESULTS: A consensus viewpoint is that systems need to be in place to ensure the safe provision of pharmacogenomics information that is curated, actionable and up-to-date. Standards should be established with respect to notification and information exchange, which could impact new or existing prescribing and these must be in keeping with routine practice. Alerting systems should contribute to safer practices. CONCLUSION: Ensuring pharmacogenetics information is available to make safer use of medicines will require a major effort, of which this guidance is a beginning. Standards are required to ensure useful genomic information within the health record can be communicated to clinicians in the right format and at the right times to be actioned successfully. A multidisciplinary group of stakeholders must be engaged in developing pharmacogenomic standards to support the most appropriate prescribing.

来源:Br J Clin Pharmacol,查看原文。版权归原作者所有。

引用

  1. Carter JL, Critchlow J, Jackson S, et al. Pharmacogenomic alerts: Developing guidance for use by healthcare professionals. Br J Clin Pharmacol. 2022. PMID: 35060169. doi:10.1111/bcp.15234

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。